Literature DB >> 12775589

Haemophilus influenzae type b vaccine--booster campaign.

Paul T Heath, Mary E Ramsay.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12775589      PMCID: PMC1126037          DOI: 10.1136/bmj.326.7400.1158

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  7 in total

Review 1.  Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussis.

Authors:  J Eskola; J Ward; R Dagan; D Goldblatt; F Zepp; C A Siegrist
Journal:  Lancet       Date:  1999-12-11       Impact factor: 79.321

2.  Risk of vaccine failure after Haemophilus influenzae type b (Hib) combination vaccines with acellular pertussis.

Authors:  J McVernon; N Andrews; M P E Slack; M E Ramsay
Journal:  Lancet       Date:  2003-05-03       Impact factor: 79.321

3.  Rising incidence of Haemophilus influenzae type b disease in England and Wales indicates a need for a second catch-up vaccination campaign.

Authors:  C L Trotter; M E Ramsay; M P E Slack
Journal:  Commun Dis Public Health       Date:  2003-04

4.  Safety and immunogenicity of a combined five-component pertussis-diphtheria-tetanus-inactivated poliomyelitis-Haemophilus B conjugate vaccine administered to infants at two, four and six months of age.

Authors:  E Mills; R Gold; J Thipphawong; L Barreto; R Guasparini; W Meekison; L Cunning; M Russell; D Harrison; M Boyd; F Xie
Journal:  Vaccine       Date:  1998-04       Impact factor: 3.641

Review 5.  Haemophilus influenzae type b vaccine: reconstitution of lyophilised PRP-T vaccine with a pertussis-containing paediatric combination vaccine, or a change in the primary series immunisation schedule, may modify the serum anti-PRP antibody responses.

Authors:  E Vidor; A Hoffenbach; M A Fletcher
Journal:  Curr Med Res Opin       Date:  2001       Impact factor: 2.580

6.  Estimating Haemophilus influenzae type b vaccine effectiveness in England and Wales by use of the screening method.

Authors:  Mary E Ramsay; Jodie McVernon; Nick J Andrews; Paul T Heath; Mary P Slack
Journal:  J Infect Dis       Date:  2003-07-31       Impact factor: 5.226

7.  Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants.

Authors:  R Dagan; J Eskola; C Leclerc; O Leroy
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

  7 in total
  6 in total

1.  Booster campaign is no incentive for parents.

Authors:  J G Daniels
Journal:  BMJ       Date:  2003-06-28

2.  Understanding the impact of Hib conjugate vaccine on transmission, immunity and disease in the United Kingdom.

Authors:  J McVernon; M E Ramsay; A R McLean
Journal:  Epidemiol Infect       Date:  2007-08-03       Impact factor: 2.451

3.  Changes in ascertainment of Hib and its influence on the estimation of disease incidence in the United Kingdom.

Authors:  S Ladhani; M P Slack; P T Heath; M E Ramsay
Journal:  Epidemiol Infect       Date:  2006-11-09       Impact factor: 2.451

Review 4.  Haemophilus influenzae type b conjugate vaccines.

Authors:  Dominic F Kelly; E Richard Moxon; Andrew J Pollard
Journal:  Immunology       Date:  2004-10       Impact factor: 7.397

Review 5.  Bacterial meningitis: the impact of vaccination.

Authors:  Nick Makwana; F Andrew I Riordan
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

6.  Progress in vaccination against Haemophilus influenzae type b in the Americas.

Authors:  M Carolina Danovaro-Holliday; Salvador Garcia; Ciro de Quadros; Gina Tambini; Jon K Andrus
Journal:  PLoS Med       Date:  2008-04-22       Impact factor: 11.069

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.